MarketScreener Homepage > Equities > Xetra > Sartorius AG SRT DE0007165607

Report

Delayed Xetra - 03/05 11:35:00 am
350	EUR		-3.58%

03/06

SARTORIUS : is a corporate partner of the Healthcare...

02/24

SARTORIUS STEDIM BIOTECH : The trend should regain control

02/18

SARTORIUS : Conference Call FY|2020 Presentation

Summary

Quotes 5-day view Delayed Quote.

Delayed Xetra

03/01/2021	03/02/2021	03/03/2021	03/04/2021	03/05/2021	Date
395(c)	389(c)	375(c)	363(c)	350(c)	Last
1 799	2 912	2 572	4 067	4 835	Volume
+0.51%	-1.52%	-3.60%	-3.20%	-3.58%	Change

More quotes

Financials

Sales 2021	2 878 M 3 433 M 3 433 M
Net income 2021	353 M 421 M 421 M
Net Debt 2021	1 814 M 2 163 M 2 163 M
P/E ratio 2021	74,9x
Yield 2021	0,32%

Sales 2022	3 241 M 3 865 M 3 865 M
Net income 2022	420 M 501 M 501 M
Net Debt 2022	1 778 M 2 120 M 2 120 M
P/E ratio 2022	65,6x
Yield 2022	0,36%

Capitalization	25 587 M 30 482 M 30 515 M
EV / Sales 2021	9,52x
EV / Sales 2022	8,44x
Nbr of Employees	10 637
Free-Float	46,8%

More Financials

Company

Sartorius AG specializes in the design, manufacturing and marketing of medical equipments for the pharmaceutical, chemical and food processing industries. The group also develops mechatronic instruments for industrial and laboratory applications. Net sales break down by family of products as follows: - biotechnological equipments (75.1%): fermentation, filtration, process, membrane chromatography and fluids storage...

Sector

Advanced Medical Equipment & Technology

Calendar

03/26

Shareholder meeting

More about the company

Notations Surperformance© of Sartorius AG

Trading Rating :

Investor Rating :

More Ratings

All news about SARTORIUS AG

03/06	SARTORIUS : is a corporate partner of the Healthcare...	PU
02/18	SARTORIUS : Conference Call FY\|2020 Presentation	PU
02/18	SARTORIUS STEDIM BIOTECH SA : Communiqué de mise à disposition de documents	DJ
02/15	DGAP-AFR : Sartorius AG: Preliminary announcement of the publication of financi..	DJ
02/15	SARTORIUS AG : Preliminary announcement of the publication of financial reports ..	EQ
02/11	SARTORIUS : Resolutions of the Supervisory Board of Sartorius AG	PU
02/10	SARTORIUS VORZUEGE : DZ Bank gives a Sell rating	MD
02/09	SARTORIUS : SIMCA® 17 Now Available with Improved Spectroscopy Modeling for PAT	PU
02/05	SARTORIUS : Polytec jumpstarts collaboration with Sartorius Data Analytics AB	PU
02/04	SARTORIUS VORZUEGE : UBS reiterates its Sell rating	MD
02/03	SARTORIUS STEDIM BIOTECH SA : Declaration relative to the number of shares and ..	DJ
02/01	SARTORIUS VORZUEGE : Raised to Buy by Deutsche Bank	MD
01/29	SARTORIUS VORZUEGE : NorldLB gives a Neutral rating	MD
01/29	SARTORIUS VORZUEGE : Berenberg remains Neutral	MD
01/29	SARTORIUS VORZUEGE : Receives a Buy rating from JP Morgan	MD

More news

News in other languages on SARTORIUS AG

03/06	SARTORIUS : ist Partner der Healthcare Businesswomen's Association
03/04	BLICKPUNKT/10 DAX-Aufsteiger für September - Porsche dabei
03/04	BLICKPUNKT/DAX ist und bleibt Index der analogen Wirtschaft
03/03	DGAP-HV : TUI AG: Bekanntmachung der Einberufung -27-
03/03	Aktien Frankfurt Schluss: Dax auf Achterbahnfahrt nach Rekordhoch

More news

Analyst Recommendations on SARTORIUS AG

02/10	SARTORIUS VORZUEGE : DZ Bank gives a Sell rating	MD
02/04	SARTORIUS VORZUEGE : UBS reiterates its Sell rating	MD
02/01	SARTORIUS VORZUEGE : Raised to Buy by Deutsche Bank	MD

More recommendations

Provided by Scoopnest.com

Chart SARTORIUS AG

Duration : Period :

Sartorius AG Technical Analysis Chart | MarketScreener

Full-screen chart

Technical analysis trends SARTORIUS AG

	Short Term	Mid-Term	Long Term
Trends	Neutral	Neutral	Bullish

Technical analysis

Income Statement Evolution

More Financials

Consensus

Sell

Buy

Mean consensus	HOLD
Number of Analysts	5
Average target price	331,25 €
Last Close Price	350,00 €
Spread / Highest target	48,6%
Spread / Average Target	-5,36%
Spread / Lowest Target	-80,4%

Consensus

EPS Revisions

More Estimates Revisions

Managers and Directors

Name	Title
Joachim Kreuzburg	Chief Executive Officer
Rainer Lehmann	Chief Financial Officer
Lothar Kappich	Chairman-Supervisory Board
Oscar-Werner Reif	Head-Research & Development
Volker Niebel	Head-Production, Procurement & Business Operations

More about the company

Sector and Competitors

	1st jan.	Capitalization (M$)

SARTORIUS AG	1.45%	30 482



REVENIO GROUP OYJ	3.18%	1 605
VAREX IMAGING CORPORATION	36.87%	911
CELLAVISION AB (PUBL)	-4.36%	810
OXFORD IMMUNOTEC GLOBAL PLC	25.85%	562
CO-DIAGNOSTICS, INC.	41.94%	349

More Results